Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
11
Number of overlapping holdings
26.8%
% of GDOC's 43 holdings also in HRTS
28.2%
% of HRTS's 39 holdings also in GDOC
Overlap by Weight
Sector Drift (GDOC minus HRTS)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in GDOC |
Weight in HRTS |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.4% | 6.4% | 6.4% |
|
AMGEN INC | 4.6% | 5.1% | 4.6% |
 |
NOVO NORDISK A/S-B | 5.8% | 3.6% | 3.6% |
 |
ASTRAZENECA PLC | 6.2% | 3.1% | 3.1% |
|
BOSTON SCIENTIFIC CORP | 5.9% | 3.1% | 3.1% |
Position Highlights (Non-Overlapping Exposures)
GDOC Overweight Relative to HRTS
|
INTUITIVE SURGICAL INC | 5.0% |
|
ABBVIE INC | 4.7% |
|
ELI LILLY & CO | 4.0% |
|
DANAHER CORP | 3.8% |
 |
METTLER-TOLEDO INTERNATIONAL | 3.4% |
|
NEUROCRINE BIOSCIENCES INC | 3.4% |
|
HUMANA INC | 3.4% |
|
COOPER COS INC/THE | 3.3% |
|
ABBOTT LABORATORIES | 3.1% |
|
ASTRAZENECA PLC | 3.1% |
GDOC Underweight Relative to HRTS
|
VERTEX PHARMACEUTICALS INC | -5.7% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -3.9% |
|
CRINETICS PHARMACEUTICALS INC | -3.8% |
|
BRIDGEBIO PHARMA, INC. | -3.8% |
|
ALNYLAM PHARMACEUTICALS INC | -3.7% |
|
CYTOKINETICS INC | -3.3% |
|
ASCENDIS PHARMA A/S | -3.1% |
 |
MEDTRONIC PLC | -3.0% |
|
MIRUM PHARMACEUTICALS, INC. | -2.6% |
|
MASIMO CORPORATION | -2.5% |